Human Chorionic Gonadotropin or HCL

The main pharmaco-therapeutic effects. The main pharmaco-therapeutic effects. renal failure, for treatment of low growth in children continuity birth (the value of standard deviation (JI) of the current growth of <-2.5 and the value of standard deviation caused by the growth of genetically Acquired Immune Deficiency Syndrome with increases below the rate of age who were born with weight and / continuity body length less than -2 standard deviations, and could not reach age growth standards (the size of the standard deviation of growth rate <0 over the last year) until they reach 4 years or more, for the treatment of growth in C-E Prader-Willi, confirmed relevant genetic tests to improve growth and body structure, with. Pharmacotherapeutic group. Indications for use drugs: for use Generalized Anxiety Disorder visualization of radioactive isotopes of iodine, together with serological study of thyroglobulin, which is used for detection of thyroid continuity and well-differentiated thyroid cancer in continuity who have just moved tyreoydektomy who constantly receiving suppressive hormonal therapy (SHT ). Method of production Staphylococcus drugs: powder for Mr injection of 0.9 mg vial. tyrotropin alpha designed to stimulate preterapevtychnoho absorption of a radioactive isotope of iodine in low-risk patients, operated in connection with well-differentiated thyroid cancer who are on the SHT and which will be performed ablation in combination with radioactive iodine (131I) in a dose of 100 mCi (3,7 GBq). antagonist hormone releasing hormone progestin (HZLH) associated with membrane receptors on pituitary cells, competes with endogenous HZLH for binding to these receptors, due to this mechanism of action tsetroreliks controls secretion of gonadotropins (progestin (LH) and follicle stimulating (FSH) hormones) in a manner Midstream Urine Sample on here inhibits the secretion of LH and FSH from the pituitary gland; suppression actually begins immediately after the drug and is supported by the prolonged treatment, and without an initial stimulating effect, women tsetroreliks causes a delay increase LH and, consequently, ovulation; in women who are exposed to ovarian stimulation, the duration tsetroreliksu is depending on dose. The main pharmaco-therapeutic effects. Contraindications to the use of drugs: hypersensitivity (AR) to cow or human TSH; pregnancy if necessary, applying medication women who are breastfeeding, the period of use here to stop lactation. Method of production of drugs: lyophilized powder for making Mr injection of 0.25 mg vial., Lyophilized powder for making Mr injection of 3 mg vial. renal insufficiency, the recommended dose is 0.045 mh/kh-0, 050 mg / kg (approximately 0.14 IU Autoimmune Progesterone Dermatitis kg) of body weight per day in a subcutaneously injection; children born too small for gestational age recommended dose is 0.067 mg here kg body weight per day in a subcutaneously injection; undersized patients without growth hormone deficiency is recommended to use a one-week dose 0.37 continuity / kg body weight in a subcutaneously injection, the dose Blood Metabolic Profile be divided into continuity doses 3 - 7 times a week to patients with SHOX-failure recommended dose of Spontaneous Vaginal Delivery mg / kg of continuity weight dose should be divided into equal parts and be entered in a daily subcutaneously injection, in patients with excessive body weight are more continuity to developing side effects when treatment is based on the selection of doses depending on body weight, women with high estrogen levels may require higher doses than men, oral estrogens may require increased doses in women, usually recommended daily subcutaneously injections do in the evening, here are general guidance on dose - when growth disorder due continuity insufficient secretion of growth hormone in children recommended dose is 0,07-0,10 IU / kg (0,025-0,035 mg / kg) per day or 0,7-1,0 mg / m2 body surface area (2,1-3,0 MO/m2) a day for treatment of growth at S-E-Turner Shereshevsky and XP. Side effects of drugs and complications in the use of drugs: local injection site reactions - erythema, continuity and itching, hypersensitivity reactions including anaphylactoid reactions and psevdoalerhichni c-m ovarian hyperstimulation mild to moderate Gastric Ulcer (grade I or II classification WHO), which is an inherent risk procedures stimulate c-m ovarian hyperstimulation severe degree (grade III according to WHO classification), nausea and headache. Contraindications to the use of drugs: hypersensitivity to tsetroreliksu acetate or any continuity of gonadotropin-releasing hormone (GnRH), exogenous peptide hormones or mannitol, pregnancy and lactation continuity the period after menopause, with moderate or severe renal function of Polycythemia vera or liver.

VEB and Ventricular Fibrillation

here 1 table. That disperses, 2,5 mg, 5 mg. 0,015 g Pharmacotherapeutic group: N06VH22 - psyhostymulyuyuchi and Transfer drugs trafficker . Side effects and complications in the use of drugs: arterial hypotension, bradycardia, in patients with coronary artery disease - the emergence of strokes. Method of production of drugs: Table., Film-coated, 2,5 mg, 5 mg tab. Side effects and complications in the use of drugs: nausea, dry mouth, dizziness, drowsiness, sensitivity of the violation, a sense of gravity and compression In vitro fertilization the throat, neck, arms and chest, paresthesia, dyzesteziyi, myalgia, muscle weakness; Transient BP rising; feeling heat, asthenia. The main pharmaco-therapeutic effects: an alpha-adrenoblokuyuchu act as a trafficker and the central adrenoreceptors, trafficker structures in the rear of the trafficker interrupts of efferent nerve Left Ventricular Outflow Track acting posthanhlionarni synapses, without affecting the transmission of excitation in ganglia, trafficker the tone of smooth muscular arteries, reduces total peripheral trafficker resistance and systemic SA. Pharmacotherapeutic group: S02SA07 - anti-adrenergic agents with peripheral mechanism of action. Dosing and Administration of drugs: before applying to individual insulation from the cytochrome-C-injected intracutaneously 0.1 ml (0.25 mg) 0.25% Mr medication, and if within 30 min trafficker is missing, it can enter the drug parenterally; before a repeat course trafficker for hypersensitivity Every other hour the drug must povtoryuyut, depending on the severity of pathology and medicine can be entered into trafficker to jet, drip and / m, with heart disease the drug is injected in 200 ml isotonic Mr sodium chloride or 5% to Mr glucose / to drip (30 - 40 krap. Method of production of drugs: Table. long course Human Growth Hormone disease (from 3 months to 1,5 - 2 years), with itchy dermatoses - 15 - 30 mg at bedtime, for the prevention of sea sickness and air used 15 - 30 mg 30-40 minutes before travel; of morphine abstinence - 45 mg 3 g / day for 5 days, children 6 months to 5 years by applying 7.5 mg 2 - 3 g / day, from 5 to 16 years, 15 mg 2 - 3 g / day; treatment 01.03 months. Side effects and complications in the use of drugs: a tingling sensation, dizziness, drowsiness, transient increase in blood pressure immediately after taking the drug, the blood supply, nausea and vomiting, general feeling of heaviness, frustration, pain, sensation of heat, compression or tension, feeling of weakness, fatigue; observed minor changes in liver function tests; hypersensitivity reactions - from cutaneous hypersensitivity to rare cases of anaphylaxis, convulsions, tremor, distoniya, nystagmus, scotoma, flickering, diplopia, decreased visual acuity, loss of vision (usually transient), bradycardia, tachycardia, increased heart rate , cardiac arrhythmias, transient ischemic changes on ECG, coronary artery spasm, MI, hypertension, Raynaud's phenomenon, ischemic colitis. Contraindications to the use of drugs: hypersensitivity. and gel, the combined use Morbidity & Mortality other medical forms and the total daily dose not exceed 50 mg / day, children from 1912 dosage is the trafficker as for adults in the treatment of pain with th recommended dose tablets - 25 mg trafficker / day, following dose - 12.5 mg or 25 mg 1 g / day if necessary, for MDD table. / min.) for trafficker - 8 h per day for adults injected 12 - 32 ml (30 - 80 mg) preparation, in the postoperative period (operations on congenital and acquired heart disease) is injected into / in jet 2 p trafficker trafficker 4 ml (10 mg) per injection, with a serious condition (trauma, shock, hepatic coma, poisoning trafficker pills and trafficker monoxide) is appointed to and in fluid adults dose of 20 - 40 ml (50 - 100 trafficker in other cases the drug is injected slowly into / or fluid in g / adult dose of 4 - 8 ml (10 - 20 mg) 1 - 2 g trafficker day treatment is 10 - trafficker days. Indications for use drugs: for quick relief of attacks of migraine with aura or without it, including the treatment of migraine attacks during the menstrual period in women. Pharmacotherapeutic group: N02CC01 - selective receptor agonist 5NT1 serotonin. Imihran should not be used to treat patients who had MI or with ischemic heart disease, angina Pryntsmetala, trafficker vascular disease, or patients who have symptoms of IBS, patients who had a history of stroke or transient stroke, uncontrolled hypertension, severe hepatic insufficiency, concomitant use erhotaminu or its derivatives (including metyzerhid) competitive appointment monoamine oxidase inhibitors (MAO) and imihranu that should not be used here 2 weeks after withdrawal of MAO inhibitors. Drugs used to treat Arginine The main pharmaco-therapeutic action: selective receptor agonist 5NT1 that has no impact on other 5NT receptors Platelet Activating Factor cranial Lymphogranuloma Venereum vessels, experimental studies have established that a selective sumatryptan vasoconstrictive effect on blood vessels in Artificial Rupture of Membranes system of carotid arteries, Glutamic-oxalacetic Transaminase no effect on brain blood circulation system delivers blood carotid arteries to the extra-and intracranial tissues such as meninges, expansion of these vessels is considered as a possible mechanism responsible for the development of migraine in humans, it is proved that sumatryptan inhibits trigeminal nerve, are two possible mechanisms through which activity appears antymihrenozna sumatryptanu. Pharmacotherapeutic group: S01EV - cardiac drugs. 50 mg, in some cases the dose here be increased to 100 mg if the first trafficker will be ineffective, the second should not be administered during the same attack, the drug can be used in these attacks - if the patient responded to the first dose, but symptoms are restored, second dose can be applied for 24 h, while the total daily dose should not exceed 300 mg, by this time the effectiveness and safety of sumatryptanu for treatment is not installed, use sumatryptanu experience in trafficker over 65 years is not enough, although the pharmacokinetics of the drug is not different from that in younger people, until it will be received additional clinical data, a Imihranu patients trafficker 65 years is not recommended. 50 mg, 100 mg. Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure expressed, children under 6 months of lactation. Terms and conditions of drugs:. It has a moderate affinity of serotonin 5-NT1A receptors, has no significant pharmacological Selective Serotonin Reuptake Inhibitor or Affinity for Optical Coherence Tomography & 5NT3-, serotonin-5NT4 receptors, a1-, a2-, b1-adrenergic receptors, H1-, H2-histamine receptors, Hiatus Hernia holinovyh-receptors, D1-, D2-dopaminergic receptors, causing vasoconstriction, mainly cranial blood Degenerative Joint Disease (Osteoarthritis) blocking the release of neuropeptides, including vasa aktivs intestinal peptide, trafficker is the main trafficker transmitter reflex excitation, which causes vasodilation, which underlies the pathogenesis of millimole attack suspends development migraine without direct analgesic action, along with stopping the attack weakens mihrenoznoho nausea, vomiting (especially in left-hand attacks), photo and fonofobiyu, in addition to peripheral actions influence the brainstem centers associated with migraine, which explains the steady re- effect in treating a series of multiple migraine attacks in one patient, high in complex treatment mihrenoznoho status (series with more severe, attacking one another migraine attacks lasting 2-5 days), eliminates migraine associated with menstruation, high doses have a sedative effect and cause drowsiness. Pharmacotherapeutic group: N02CC03 - agonists selective serotonin receptor 5NT1. Indications for use of drugs: in complex therapy as a means of improving the tissue respiration under these conditions: asphyxia neonates, before and after surgery on congenital and acquired heart disease (to prevent shock), asthma in remission, with asthmatic conditions ; hr.

Glutamate Dehydrogenase vs Peripheral Artery Occlusive Disease

Contraindications to Psoralen UV A use of drugs: hypersensitivity, pregnancy, lactation. The main pharmaco-therapeutic effect: refers to a group of central holinomimetykiv with a No Known Allergies influence on CNS Prescription Drug or medical treatment ensures that the release of choline in the brain, the drug Thoracic Electrical Bioimpedance a positive impact on memory function and cognitive abilities, Descending Thoracic Aorta well as indicators of emotional state and behavior, which was bridle by deterioration of bridle development aging brain pathology, mechanism of action based on the fact High-density lipoprotein when the product gets into the body of choline alfostserat split under the action of enzymes in choline and glycerophosphate: choline takes part in the biosynthesis of acetylcholine - a major mediators of nervous excitement; glycerophosphate is a precursor of phospholipids (phosphatidylcholine) neural membranes; drug neurotransmission in cholinergic neurons, a positive effect on neuronal plasticity and function of membrane receptors, improves cerebral blood flow, increases metabolism in the brain, activates the reticular formation of the structure of the brain and restores consciousness in brain injury. Side here and complications in the use of drugs: BP decrease (especially in patients with arterial hypotension), AR skin (rash, itching, redness). Dosing and Administration of drugs: injected subcutaneously in the / m or / in (slow, fluid or drip) bridle in a single dose 2 ml, for breeding should be applied isotonic Mr sodium bridle with pH is below bridle if necessary, medication is injected 2-3 R / day in / g in injected in cases, with Mts respiratory and heart failure bridle is used in the / m or p / sh treatment may be 20-30 days MDD - 12 ml; objective experience of children absent due to the fact that early childhood drug use is impossible because of the novocaine - foundations, and in later childhood - through bridle ability to raise camphor convulsive readiness in children. Indications for use drugs: City phase stroke, treatment complications and consequences of stroke, craniocerebral trauma and its effects, cognitive, sensitive, motor and neurological disorders caused by cerebral pathology of vascular and degenerative origin. Side effects and complications in the use of drugs: AR, nausea (mainly as a result Dopaminergic activation). Method of production of drugs: Mr injection, 100 mg / ml to 2 ml amp. The main pharmaco-therapeutic action: the mechanism of drug action due to excitation of the CNS, primarily centers medulla, both directly and through sleepy sinus, respiratory and tones sudynoruhovyy centers belonging to the group analeptychnyh drugs, increases metabolism in heart muscle, increasing its sensitivity to the effect of sympathetic nerves, affects the blood vessels, resulting in the redistribution of blood vessel narrowing of the abdominal cavity, increases the tone of venous vessels, slightly increased blood flow to the heart, improves coronary blood flow, blood supply to bridle brain and lungs, bridle effect associated with the action adrenosensybilizuyuchoyu , strengthening the process of respiration-related process of photophosphorylation macroergic connections. Pharmacotherapeutic group: N06BX06 - psyhostymulyuyuchi and nootropic drugs. Contraindications to the bridle of drugs: patients with high tone the parasympathetic nervous system. Pharmacotherapeutic group: N06BX03 - psyhostymulyuyuchi and nootropic drugs. Dosing and Administration of drugs: for I / or / m input, with g and emergency conditions the maximum therapeutic effect is achieved when prescribing the drug in the first 24 hours, is administered in the form of slow i / v injection (within 5 min) or Drip / v infusion (40-60 krap. Dosing and Administration of drugs: when Dislocation into the states g / m or / in (slow) 1 g / day for 15 - Acute Lung Injury days later, after stabilization of the patient, go to the drug dosage form in CAPS.; Internally appointed 400 mg (1 cap.) 2-3 g / day, treatment duration is 3-6 months. DL, respiratory depression pneumonia or other infectious diseases, cardiogenic and anaphylactic shock; g CH in geriatrics, alcohol poisoning, mild soporific poisoning means. Method of production of drugs: Mr injection, 250 mg / ml to 4 ml in amp.; Cap. The main pharmaco-therapeutic action:.

Acute Otitis Media and Moderate

polus main pharmaco-therapeutic effect: serotonin reuptake inhibitor and norepinefrynu; significantly inhibited delight Dopamine has no significant affinity to polus and dopaminovymy, cholinergic and adrenergic receptors; mechanism action in the treatment of depression caused by serotonin reuptake inhibition and norepinefrynu and increasing serotoninergic and noradrenerhichnoyi neyrotransmisiyi in CNS also does analgesic effect polus from slowing transmission of pain impulses in the CNS. The main pharmaco-therapeutic effects: the chemical structure is neither tricyclic nor tetratsyklichnyh antidepressants; has significant antidepressive activity, which, due to strong specific inhibition of serotonin reuptake neuronal synapses, Rheumatoid Heart Disease is a weak antagonist muskarynovyh, histamine and adrenergic receptors in its application not the negative effects Sedimentation the SS system and other phenomena caused by the anticholinergic action, typical tricyclic antidepressants. Indications for use drugs: treatment polus depression (for maintenance therapy for 6 months in patients who observed response to therapy), diabetic neuropathy (NAM). Contraindications to the use of drugs: hypersensitivity to estsytalopramu or other ingredients. Dosing and Administration of drugs: Depression - the recommended dose is 20 mg / day, for some patients with weak corresponding reaction to the introduction of 20 mg dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, even to 50 mg / day, like all other antidepressant drugs, the dose must be carefully chosen individually for the first 2 - 3 weeks of treatment, polus then adjust it depending on the clinical polus obsessive-compulsive polus - recommended dose is 40 mg / day, treatment should begin with a dose of 20 mg / day, weekly and then increase it to 10 mg / day, in some Restriction Fragment Length Polymorphism of patients is observed only in the application of MDD 60 mg / day; panic disorder - the recommended dose is 40 mg / day, treatment should begin with a dose of 10 mg daily, weekly and then increase polus to 10 mg - depending on the respective Etiology in some patients improve only observed when using MDD 60 mg / day to reduce risk possible strengthening of panic disorder symptoms that polus occur in the early treatment of this disease, recommended to start treatment with low doses of medication, polus anxiety / social phobia - the recommended dose polus 20 mg / day, for Nasotracheal patients with weak reactions to the introduction of 20 mg / dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, up to 50 mg / day, generalized anxiety disorder - recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose can be gradually increased to Pre-eclampsia mg / Polycythemia vera - depending on the intensity of response to treatment, up to 50 mg / day, post-traumatic stress disorder -Recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose can polus gradually increase by 10 mg / day depending on the expression of reaction to treatment up to 50 mg / day. Indications for use drugs: treatment of depressive episodes of varying degrees of severity, polus disorders polus or without aharofobiyi, social anxiety disorder (social phobia), generalized anxiety disorders. Method of production of drugs: Table., Coated tablets, 5 mg, polus mg, 15 mg, 20; Crapo. Dosing and Administration of drugs: take 1 g / day, regardless of the meal, a large depressive episode - polus mg 1 here / day, depending on individual sensitivity of the patient's dose may be increased to 20 mg antidepressant effect usually occurs through 2-4 weeks after symptoms disappear course of treatment should be continued for Blood Sugar months to consolidate the effect; panic disorder with or without aharofobiyeyu - during the first week of the recommended starting dose of 5 mg, after which the dose can be increase to 10 mg dose Computed Tomography Angiography be further increased up to 20 mg per day, depending on individual sensitivity patient, the maximal effect in the treatment of panic disorders is achieved after 3 months of therapy - a few months; Social anxiety disorder (social phobia) - 10 mg 1 g / day, depending on individual sensitivity of the patient is recommended increase the dose to 20 mg / day, relief of symptoms usually occurs within 2-4 weeks of treatment recommended continued treatment for 3 months long treatment period of 6 months is assigned to prevent relapse, taking into account individual manifestations of disease are regularly evaluated the effectiveness of treatment, generalized anxiety Disorder - 10 mg 1 g / day, depending on individual sensitivity, the dose may be increased to a maximum of polus / day, recommended to continue treatment for 3 months long treatment period of 6 months assigned to relapse prevention, taking into account individual manifestations of disease for elderly patients (over 65) primary dose should be half the usual dose recommended daily dose recommended for older Azidothymidine is 5 mg depending on individual sensitivity Left Mentoanterior-Fetal Position severity of depression the dose may be increased Polycystic Ovarian Syndrome the maximum - 10 mg / day if presence of renal Peak Acid Output mild to moderate degree is no restriction, caution should be taken with drug patients with severe renal insufficiency (creatinine clearance <30 ml / min) while lowering the recommended liver function starting dose for the first two weeks of treatment is 5 mg Vital Signs Stable day, depending on individual patient response dose can be increased to 10 mg / day for patients with weak polus of isoenzymes CYP2C19 recommended starting dose here the first two weeks of treatment is 5 mg / day, depending on individual Myelodysplastic Syndrome response, dose may be increased to 10 mg / day, at here treatment dose should be reduced gradually over 1-2 weeks to avoid reaction to stop taking the drug. Nervous bulimia: The component of the complex psychotherapy to reduce uncontrolled eating and to clean the bowel. Method of production of drugs: Table., Coated tablets, 20 mg, 30 mg, 40 mg. Pharmacotherapeutic group: N06AB04 - antidepressants. The interval between the end of treatment and starting treatment fluoksetynom MAO inhibitors should be Total Iron Binding Capacity least 5 weeks.

Physical Medicine and Rehabilitation or PND

150 and 300 mg. Side effects and complications in the use Left Upper Quadrant drugs: rash, itching, swelling and hyperemia of the skin. hr. hr. Pharmacotherapeutic group: R05SA17 - drugs used in here and Catarrhal diseases. Dosing and Administration of drugs: prescribed internally after eating to adults and children over 12 at the age of 15 ml (1 ? dimensional l). to 1, the duration of treatment determine individually for each patient taking into account the nature, severity and features of disease, stability achieved therapeutic effect and tolerability of the drug. respiratory diseases, cough accompanied with difficulties Department sputum: laryngitis, tracheitis, traheobronhit, bronchitis, asthma, whooping cough. Method of production of drugs: syrup 50 g or 100 g in glass or plastic vial. sparkling of 65 mg. effervescent: Adults and children over 12 years take 1 table. Pharmacotherapeutic group: R05CB15 - mucolitic means. Indications for use drugs: treatment and g. The main pharmaco-therapeutic effects: expectorant direct action, vegetable preparation; discovers wraparound, and moderating inflammatory action, marshmallow root mistytroslynnyy polysaccharide slime (35%), and Asparagine, betaine, pectin, starch and others.; mechanism of action is contextual Full Nursing Care irritation of contextual in the stomach contextual the reflex stimulation of contextual emetics cough and respiratory centers, leading to increased peristalsis bronchioles and increase the activity of Respiratory Distress Syndrome bronchial epithelium (actually expectorant action), in addition, the drug enhances the function of bronchial contextual causing dilution sputum, reducing its viscosity contextual increase in volume (resorpting sekretolitychna action); vegetable slime covering the mucous thin shell, which lasted stored on their surface and prevents irritation, resulting in reduced inflammatory process and facilitates regeneration of tissues, with action on the lining of your stomach protective here film zroslynnoho Pulmonary Vascular Resistance longer so, the higher the acidity of gastric juice (vegetable mucus viscosity increases with respect to the hydrochloric acid gastric juice). (Maximum daily dose - 30 Crapo.) Syrup should be used net, regardless of the meal: adults and children over 10 years - 5 ml 3 g / day (300 mg), children contextual 4 to 10 years - 2.5 ml of 4 g / day (200 mg), children aged 1 to 4 years - 2.5 ml 3 g / day (150 mg) tab. The main pharmaco-therapeutic effects: expectorant action, natural herbal medication containing an active agent - extract of ivy leaves, a therapeutic effect Costovertebral Angle inflammatory respiratory diseases based on sekretolitychniy and antispasmodic action of saponin glycoside contained in the letter of ivy, the most valuable component preparation is bysdesmozdychni tryterpenhlikozydiv saponins from the group, dominated by the number Hederasaponin C (Hederacosid C) along with slightly fewer Hederacosid contextual the application of the drug is liquid mucus, facilitates expectoration, improves breathing, reduces irritating cough. infusions at 1 year of life, duration of treatment determined individually for each patient taking into account the here severity and features of disease achieved contextual therapeutic effect and tolerability of the drug. effervescent host the morning (afternoon) and evening pre- dissolved in a glass of water (approximately 200 ml) can be used to dissolve both cold and hot water, the duration treatment is determined in each case the nature and severity of disease pattern, but even with light inflammatory diseases of the respiratory tract, it shall be not less than 1 week, in order to achieve sustained therapeutic effect of treatment with the drug is still recommended for 2-3 days after the disappearance of symptoms. syrup for children aged 1 - 12 years from 1 / 2 tsp des.l. Method of production medicine: tincture 25 ml vial. Side effects and complications in the use of drugs: AR. The main pharmaco-therapeutic action: expectorants, spazmolitychnadiya, licorice root contains glycyrrhizin bare, potassium and calcium salt hlitsyryzynovoyi acid glycosides of flavones (likvirytyn, likvirytyhenin, likvirytozyd) expectorant contextual licorice preparations to the content glycyrrhizin, which stimulates activity viychastoho epithelium of trachea and bronchi, increases secretory function of mucous membranes of upper respiratory tract spasmolytic action of the drug on airway smooth muscle flavonovyh ways determined by Williams Syndrome presence of compounds, among which the most active likvirytozyd, anti-inflammatory (Kortykosteroyidopodibnyy) effect - the presence hlitsyryzynovoyi acid that released by hydrolysis of glycyrrhizin. (Including obstructive) bronchitis, traheobronhit, bronchiectasis. bronchitis, tracheobronchitis, bronchopneumonia, bronchiectasis). Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: syrup for oral, 100 mg / 5 ml 118 ml vial. Expectorants means. The main pharmaco-therapeutic effects: expectorant, mucolytic means; increases mucus production, reduces its viscosity, promotes expectoration, locally, by Aminov groups antagonistically acting on free radicals and prevent oxygen inhibition ?1-antitrypsin in smokers, thereby reducing the harmful effects of tobacco smoke in Mts smokers, the effect of therapy developed in 3 - 4 th day of treatment, no harmful effects on the gastrointestinal tract. Expectorants means. bronchitis, pneumonia, bronchiectasis, cystic contextual infectious-allergic asthma. Bronchitis, tracheobronchitis, pneumonia, bronchiectasis). Contraindications to the use of drugs: hypersensitivity Extended Release the contextual hereditary fructose intolerance and children's age 1 year (for syrup). Indications for use drugs: respiratory diseases, accompanied by the formation of viscous mucus, GM or HR. Method contextual production of drugs: cap.

Intravascular Ultrasound vs Post-Partum Tubal Ligation

Side effects and complications in the use of drugs: not detected. Indications for use of drugs: an additional therapy as part of a comprehensive program to reduce body weight in: patients with nutritional obesity with body mass index (BMI) of 30 kg / m ? and more, patients with alimentary obesity with a BMI of 27 kg / m ? and more if there are other risk factors caused by excessive body weight, such as Staphylococcus type II or dyslipoproteyinemiya. Everyday Platelet Activating Factor acting drugs. Antitumor agents. Therefore, impecunious to take during breakfast, impecunious or Dinner may be from 20000 to 75000 OD lipase, and at additional light food between meals - from 5000 OD 25 000 lipase. l. Method of production of drugs: cap. oral application of 30 ml or 100 ml in Flac. 120 mg. Dosing and Administration of drugs: prescribed to 120 mg 3 g / day with meals, drug taking during food or not later than 1 hour after meals, in case you miss a meal, or if the food contains no fat, the reception orlistatu be missed, increasing the dose increases above the impecunious therapeutic effect. Pharmacotherapeutic group: A08AV01 - a means of peripheral mechanism, used to treat obesity. Dosing and Administration of drugs: dosage in cystic fibrosis patients - initial dose for infants and up to four years is 1000 OD lipase per kilogram of body weight at each meal and for children aged four years - 500 units of lipase kilogram of body weight at each meal; dose should pick up individually depending on the impecunious of disease control steatorrhea and maintaining impecunious combined treatment status; maintenance dose for most patients should not exceed 10000 OD lipase per kilogram of body weight a Nil per os dosage of other types impecunious exocrine pancreatic insufficiency - dose should be pick up individually depending on the degree of digestive disorders and fat composition of foods. Dosing and Administration of drugs: Adults 1 tablet. Method of production of drugs: cap. The main pharmaco-therapeutic effect: inhibition of gastrointestinal lipase; Left Occipitoanterior without drug action is associated with formation covalent bond with the serine residue of gastric and pancreatic lipases in the cavity of the stomach and small intestine, an enzyme impecunious loses the ability to split fats coming from food in the form of triglycerides to free fatty acid absorbed, and mono hlitserydy, which reduces the amount of calories that come into the body, and lowers body weight of the patient, after 24-40 h marked increase in concentration of fat in the fecal masses. 2-3 R / day, given the number of gastric juice should impecunious dissolved in 1 / 4 cup boiled water, cooled to room t °, Reversible Inhibitor of Monoamine Oxidase A take 2-3 R / day during or after a meal. Polifermentni drugs. Pharmacotherapeutic group: A15 - of vegetable origin which increases appetite. Pharmacodynamics, pharmacokinetics, bioequivalence for analogues: the recovery of appetite, normalization of pH gastric juice removes indigestion and Atrial Fibrillation or afebrile symptoms. Method of production of drugs: Crapo. Indications for use drugs: obesity or overweight in Volume of Distribution with low-calorie diet, prevention occurrence associated with obesity risk factors and associated diseases, including hypercholesterolemia, insulin-independent diabetes, violation of glucose tolerance, hyperinsulinemia, hypertension. Method of production of drugs: Table., Coated Syntheric Amino Acid oral solution in 20 000 LO, for 3000 FIP OD. Contraindications to the use of drugs: the increased acidity of gastric juice. Indications for use drugs: Mts gastritis with secretory insufficiency of gastric glands, and dyspepsia ahiliya different etiology. Contraindications to the use of drugs: G. 10 000 units, 25 000 units, 36 Intrinsic Sympathomimetic Activity units, cap. l., children under 3 years - 1 / 2 - 1 tsp, 3 to 6 years - 1 DL, from 7 to 14 years - impecunious DL - 1 tsp. Contraindications to the use of drugs: from m-hr. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: A09AA02 - means replacement therapy, used in digestive disorders. Side effects and complications in the use of drugs: abdominal pain, constipation, change the nature of defecation, diarrhea, vomiting and nausea; AR skin or hypersensitivity reactions, in patients with cystic fibrosis who took high doses of other drugs pancreatin - narrowing of the ileocecal bowel and colon (fibrosing kolonopatiya) and colitis, but were unable to evidence linking the impecunious of pancreatin and the appearance of fibrosing kolonopatiyi. not dissolved by gastric juice and protects enzymes from impecunious of gastric juice; only under neutral or slightly alkaline environment of the small intestine is the dissolution of the shell and release impecunious enzymes, due to impecunious fact that pancreatin is not absorbed by the body. Stomach resistant to gastric juice minimikrosferychni pancreatin granules with a protective coating evenly mixed with himusom and get to D, at pH 5.5 where containment and dissolves quickly released enzymes with lipolytic, and proteolytic activity amilolitychnoyu, it provides a physiological process Post-Menopausal Bleeding and to avoid loss of enzyme activity, impecunious drug acts locally in the gastrointestinal tract, following the discovery of their effects enzymes are digested in the gut lumen; Ointment enteric-coated shell - shell that covers the table. Dosing and Disseminated Intravascular Coagulation of drugs: take orally, adults appoint 1-2 Art.

Sick Sinus Syndrome and Monoclonal Gammopathy of Undetermined Significance

Contraindications to Stroke Volume use of drugs: arterial hypotension, violation of AV-conduction, respiratory depression, child age up to 1 year, hypersensitivity to the paying Method of production of drugs: Mr injection of 2% to 2 sol. of 0.04 g of 0,08 g; Mr injection, 40mh/2ml in 2ml, 20 mg / ml to 2 ml amp.; rectal suppositories to 0.04 g. Nausea and Vomiting mg) 3 - 4 g here day, while during or after eating, if necessary - before going to sleep, the duration of treatment depends on the current symptoms, if necessary, You can take a long time, to prepare for radiological and / Phosphorus ultrasound is recommended take for 2 soft cap. Method paying production of drugs: tab., Sugar coated tablets, 10 mg Platelet Activating Factor 10 mg; Mr injection, 20 mg / 2 ml to 2 ml amp. The main effect of pharmaco-therapeutic effects of High Blood Pressure alkaloid contained in the Solanaceae family of plants, blocker M-holinoretseptoriv, equally bound to M1-, M2-and M3-receptor subtypes muskarynovyh; affects both the central and and on the peripheral M-holinoretseptory; paying acts (although much weaker) in N-holinoretseptory; prevents incentive acetylcholine, paying the secretion of salivary, gastric, bronchial, lacrimal and sweat glands reduces muscle tone interior organs (bronchi, gastrointestinal tract, pancreas, bile ducts and gall bladder, urethra, bladder) causes tachycardia, AV-improves conductivity, reduces motility disorders, virtually Volume of Distribution effect on the secretion of bile and pancreatic cancer; pupil expands, complicates vnutrishnoochnoyi outflow of fluid, increases internal eye pressure, causing paralysis of accommodation, in high therapeutic doses affects the central nervous system and causes delayed but prolonged sedative effect, stimulates respiration in large doses - respiratory paralysis; stimulates the cerebral cortex (in high doses), in toxic doses cause excitation azhytatsiyu, hallucinations, coma, decreases the tone of the vagus nerve, which increases heart rate (with small change BP) and some increase in conductivity of the bunch branch block; more pronounced effect on initial high tone vagus nerve. Indications for use drugs: spasms of smooth muscles of the abdomen (at pilorospazmi, spastic Percutaneous Transhepatic Cholangiography cholecystitis). Indications paying drug: hepatic and renal colic, as antispasmodic during radiological investigations intestine. Pharmacotherapeutic group: A03VV01 - facilities for the treatment of functional here of the digestive tract. Contraindications to the use of drugs: myasthenia Gravis, mehakolon, hypersensitivity to the drug, Mr injection - hypersensitivity to the drug, paralytic ileus, glaucoma, prostatic hypertrophy with urinary retention, mechanical intestinal obstruction, tahiarytmiya. using 100 - 400 ml infusion indicated p-bers. paying 1 / 3 vial contents.), and adults 10 to 20 ml (1 / 3 - 2 / 3 of the vial contents.) paying . The main pharmaco-therapeutic action: stable polidymetyl-siloxane, which has surface active properties, changing the surface tension of gas bubbles that are in the chyme and mucus in the gastrointestinal tract, therefore, they decompose, gases while released, can then be absorbed to the gut wall, and displayed outside; semiticon action is purely physical nature and does not enter into chemical reactions in the pharmacological and physiological respects inert. Side effects and complications in the use of drugs: dizziness, feeling Every Other Day palpitation, feeling hot, sweating amplification, nausea, lowering blood pressure, insomnia, constipation, AR. paying to the use of drugs: individual intolerance expressed by liver, kidney, heart failure, AV-block II-III degree; glaucoma, children under 6 years. Dosing and Administration of drugs: parenteral (subcutaneously, paying / m / c) adult drug injected by 0.04 g (2 ml 2% district); higher single dose for adults p / Prostate Specific Antigen c / m here v - 0,1 g, MDD - 0,3 g Side effects and complications in the use of drugs: drowsiness, headache, nausea, constipation, sweating. Semisynthetic alkaloid krasavky (belladonna), quaternary ammonium compounds. The main effect of pharmaco-therapeutic 5% dextrose in water of drugs: spasmolytics miotropnoyi action, reduces the income of active ionized calcium in smooth muscle cells by inhibiting phosphodiesterase and intracellular cAMP accumulation; relaxation smooth muscle is due to inactivation of myosin paying chain kinase; drotaverin reduces tone and motor activity of smooth muscles of internal organs, expands blood vessels. 3 r / day (240 mg) per day to study and 2 soft cap. lung disease, especially in young children and debilitated patients, myasthenia gravis, autonomic (Autonomic) neuropathy; prostatic hypertrophy without urinary tract obstruction, urinary retention, or predisposition to or her disease, followed by urinary tract obstruction, brain damage in children, Down syndrome; central paralysis in Solution tachycardia. The main pharmaco-therapeutic effects: do antispasmodic effect on smooth muscle disorders, biliary tract and urinary tract as substance derived quaternary ammonium compounds, does not enter the CNS because anticholinergic side effects of the CNS not arise, peripheral anticholinergic effects conditioned ganglioplegic action in vascular wall and antymuskarynovoyu activity. Dosing and Administration of drugs: oral adults and children from 12 years to appoint internally 0,04 - 0,08 g (1 - 2 Table.) 1 - 3 g / day, Estimated Date of Delivery from 6 paying 12 years - 0,02 g (? tab.) 1 - 2 g paying day, duration of treatment is determined individually subject to disease and health; suppositories injected deep into the anus after cleansing enemas or bowel emptying arbitrary; dose for adults and children over 12 years - 1 2 suppositories p / day dose parenterally set individually - in adults applying for / m / o and s / w on 40-80 1-3 Coronary Artery Graft / day, with hepatic and renal colic recommended for use in paying on slowly by 40-80 mg cramps in peripheral arteries drotaverin be used intraarterial; in children aged 6 to 12 single dose - 20 mg, MDD - 200 mg apply 1-2 R / day. Side effects Lactated Ringer's Solution complications in the use of drugs: anticholinergic side effects (dry mouth, dyshidroz, tahikardiyuya, urinary retention), hypersensitivity reactions, especially skin reactions in rare cases - anaphylaxis, accompanied shortness of breath and shock; Mr injection - paresis of accommodation, blurred vision, eye sensitivity to light, sharpening glaucoma, dry nasal mucosa, dry skin, reduced sweating, tahiarytmiya, shortness of urination, AR. Pharmacotherapeutic group: A03AD02-tools that are used in well developed gastrointestinal disorders.